A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell Malignancies

NCT07628582 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
48
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators